Search for Clinical Trial Results
Azotemia - 25 Studies Found
Status | Study |
Terminated |
Study Name: Complement Inhibition in aHUS Dialysis Patients Condition: Atypical Hemolytic Uremic Syndrome Date: 2015-05-26 Interventions: Drug: CCX168 |
Completed |
Study Name: A Retrospective, Observational, Non-interventional Trial to Assess Eculizumab Treatment Effect in Patients With Atypical Hemolytic Uremic Syndrome (aHUS) Condition: Atypical Hemolytic Uremic Syndrome (aHUS) Date: 2012-11-13 |
Completed |
Study Name: The Safety and Efficacy of Eculizumab in Japanese Patients With Atypical Hemolytic Uremic Syndrome (aHUS) Condition: Atypical Hemolytic Uremic Syndrome (aHUS) Date: 2012-12-04 Interventions: Drug: Eculizumab |
Completed |
Study Name: To Characterize the Safety and Tolerability of Eculizumab in Two Japanese aHUS Patients Condition: ATYPICAL HEMOLYTIC UREMIC SYNDROME (AHUS) Date: 2012-12-04 |
Recruiting |
Study Name: Atypcial Hemolytic-Uremic Syndrome (aHUS) Registry Condition: Atypical Hemolytic-Uremic Syndrome Date: 2012-01-18 |
Terminated |
Study Name: aHUS Observational Long Term Follow-Up Condition: Atypical Hemolytic Uremic Syndrome Date: 2012-01-18 |
Completed |
Study Name: An Open-label, Multi-center Clinical Trial of Eculizumab in Adult Patients With Atypical Hemolytic-uremic Syndrome Condition: Atypical Hemolytic-Uremic Syndrome Date: 2010-08-31 Interventions: Drug: Eculizumab All patients received open-label eculizumab administered intravenously on the following |
Completed |
Study Name: An Open-Label, Multi-Center Clinical Trial of Eculizumab in Pediatric Patients With Atypical Hemolytic-Uremic Syndrome Condition: Atypical Hemolytic-Uremic Syndrome Date: 2010-08-31 Interventions: Drug: Eculizumab Fixed dosing is based on body weight cohorts. Adjustment of dose to accommodate patient |
Completed |
Study Name: Open Label Controlled Trial of Eculizumab in Adolescent Patients With Plasma Therapy-Resistant aHUS Condition: Atypical Hemolytic Uremic Syndrome Date: 2009-02-13 Interventions: Drug: Eculizumab All patients received open-label eculizumab administered intravenously on the following |
Completed |
Study Name: Open Label Controlled Trial of Eculizumab in Adult Patients With Plasma Therapy-Resistant aHUS Condition: Atypical Hemolytic Uremic Syndrome Date: 2009-02-13 Interventions: Drug: Eculizumab All patients received open-label eculizumab administered intravenously on the following |